// App-Quantinova.ai

4680 : Additional Consolidation after Attaining Second Complete Remission Results in Superior Outcomes after Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Sara Lozano Cerrada

Principal Investigators

  • Gabriela Rondon

  • Elizabeth J. Shpall

  • Chitra Hosing

  • Muzaffar H. Qazilbash

  • Nina Shah

  • Katy Rezvani

  • Elias Jabbour

  • Hagop M. Kantarjian

  • Richard E. Champlin

  • Partow Kebriaei

  • Celina Ledesma

  • Uday R. Popat

  • Amanda Olson

  • Amin Alousi

  • Betul Oran

  • Sairah Ahmed

  • Stefan O. Ciurea

  • Krina Patel

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved